Thiruvananthapuram, Oct 9 (UNI) Incentivising hospitals and healthcare professionals and attracting multinational companies (MNCs) to conduct clinical trials in India are crucial to scaling up biologic drug development and manufacturing, experts said at Bio Connect 4.0 here on Friday.